Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124933683 | 12493368 | 3 | F | 201604 | 20160808 | 20160623 | 20160812 | EXP | US-009507513-1606USA006424 | MERCK | 47.92 | YR | M | Y | 0.00000 | 20160812 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124933683 | 12493368 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG, QW | U | 12675 | 40 | MG | TABLET | /wk | |||||
124933683 | 12493368 | 2 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | 25 MG, QD IN 21/28-DAY SCHEDULE | U | 0 | 25 | MG | ||||||||
124933683 | 12493368 | 3 | C | PEPCID RPD | FAMOTIDINE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | WAFER | BID | |||||
124933683 | 12493368 | 4 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 90 MG, QD, FOR 90 DAYS | U | 0 | 90 | MG | TABLET | QD | |||||
124933683 | 12493368 | 5 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 500 ML, QOD | U | 0 | 500 | ML | SOLUTION FOR INJECTION/INFUSION | QOD | |||||
124933683 | 12493368 | 6 | C | ACTIGALL | URSODIOL | 1 | Oral | 300 MG, TID | U | 0 | 300 | MG | CAPSULE | TID | |||||
124933683 | 12493368 | 7 | C | DIFLUCAN | FLUCONAZOLE | 1 | Oral | 400 MG, QD | U | 0 | 400 | MG | TABLET | QD | |||||
124933683 | 12493368 | 8 | C | FOLVITE | FOLIC ACID | 1 | Oral | 2 MG, QD | U | 0 | 2 | MG | TABLET | QD | |||||
124933683 | 12493368 | 9 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, QD | U | 0 | 500 | MG | TABLET | QD | |||||
124933683 | 12493368 | 10 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Oral | 2 MG, QAM AND 2MG QPM | U | 0 | 2 | MG | CAPSULE | BID | |||||
124933683 | 12493368 | 11 | C | MAGNESIUM (UNSPECIFIED) | MAGNESIUM | 1 | Oral | 266 MG, TID FOR 90 DAYS | U | 0 | 266 | MG | TABLET | TID | |||||
124933683 | 12493368 | 12 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | 250 MG, 2 TIMES A WEEK | U | 0 | 250 | MG | TABLET | BIW | ||||||
124933683 | 12493368 | 13 | C | BACTRIM DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 1 TABLET ONCE A DAY, ON MONDAY, WEDNESDAY AND FRIDAY | U | 0 | 1 | DF | TIW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124933683 | 12493368 | 3 | Prophylaxis |
124933683 | 12493368 | 4 | Hypertension |
124933683 | 12493368 | 5 | Electrolyte imbalance |
124933683 | 12493368 | 6 | Prophylaxis |
124933683 | 12493368 | 7 | Prophylaxis |
124933683 | 12493368 | 8 | Routine health maintenance |
124933683 | 12493368 | 9 | Antiviral prophylaxis |
124933683 | 12493368 | 10 | Complications of bone marrow transplant |
124933683 | 12493368 | 11 | Routine health maintenance |
124933683 | 12493368 | 13 | Antifungal prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124933683 | 12493368 | HO |
124933683 | 12493368 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124933683 | 12493368 | Alanine aminotransferase decreased | |
124933683 | 12493368 | Aspartate aminotransferase decreased | |
124933683 | 12493368 | Asthenia | |
124933683 | 12493368 | Blood chloride increased | |
124933683 | 12493368 | Blood magnesium decreased | |
124933683 | 12493368 | Bone marrow failure | |
124933683 | 12493368 | Cerumen impaction | |
124933683 | 12493368 | Cytomegalovirus viraemia | |
124933683 | 12493368 | Diarrhoea | |
124933683 | 12493368 | Fatigue | |
124933683 | 12493368 | Gastrointestinal toxicity | |
124933683 | 12493368 | Haematocrit decreased | |
124933683 | 12493368 | Lymphocyte count decreased | |
124933683 | 12493368 | Monocyte percentage increased | |
124933683 | 12493368 | Mucosal inflammation | |
124933683 | 12493368 | Pigmentation disorder | |
124933683 | 12493368 | Red blood cell count decreased | |
124933683 | 12493368 | Renal failure | |
124933683 | 12493368 | Seasonal allergy | |
124933683 | 12493368 | Stem cell transplant |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124933683 | 12493368 | 1 | 20140707 | 0 | ||
124933683 | 12493368 | 2 | 20140707 | 0 |